在 Intacta RR2 PRO 的推动下，强劲的大豆销售帮助孟山都公司在 2015 财年第一季度实现了每股收益，超出了财年年初制定的预期。 Intacta RR2 PRO 预计将超过其 10-12 百万英亩的目标。
Overall, sales for Monsanto’s Seeds and Genomics segment in the first quarter were $1.6 billion, led by the performance of the company’s soybean business — its fastest growing growth driver. The company also expects a positive impact following the USDA’s final Environmental Impact Statement concluding that Monsanto’s Roundup Ready 2 Xtend soybeans and Bollgard II XtendFlex cotton should be fully deregulated. During its annual update, Monsanto highlighted advancements across the industry’s broadest research and development pipeline, including its breeding, biotechnology, crop protection, microbials, BioDirect and Climate platforms.
“From progress in our Roundup Ready Xtend systems to advancements in highly-relevant disease-resistance breeding traits — as well as next-generation insect control products and upgrades in our Climate services — we are seeing incredible progress across our research and development pipeline,” said Dr. Robb Fraley, chief technology officer for Monsanto.
孟山都农业生产力部门 2015 财年第一季度的净销售额约为 $12 亿美元。公司继续预计 2015 财年农业生产力部门的毛利润最多将下降 10%，这主要是受定价驱动。
阅读更多 （链接在这里）.